Specificity in structure-based drug design: Identification of a novel, selective inhibitor of Pneumocystis carinii dihydrofolate reductase
Specificity is an important aspect of structure-based drug design. Distinguishing between related targets in different organisms is often the key to therapeutic success. Pneumocystis carinii is a fungal opportunist which causes a crippling pneumonia in immunocompromised individuals. We report the id...
Saved in:
Main Authors: | Daniel A. Gschwend, Worachart Sirawaraporn, Daniel V. Santi, Irwin D. Kuntz |
---|---|
Other Authors: | University of California, San Francisco |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/17881 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Purification and properties of recombinant Pneumocystis carinii dihydrofolate reductase
by: Worachart Sirawaraporn, et al.
Published: (2018) -
Construction of synthetic genes for plasmodium falciparum dihydrofolate reductase-thymidylate synthase and Pneumocystic carinii dihydrofolate reductase
by: Phisit Prapunwattana
Published: (2023) -
Dihydrofolate reductase and antifolate resistance in malaria
by: Worachart Sirawaraporn
Published: (2018) -
Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase
by: Worachart Sirawaraporn, et al.
Published: (2018) -
Pyrimethamine analogue inhibitors of resistance mutants of Plasmodial dihydrofolate reductase
by: Ali Sardarian, et al.
Published: (2018)